Prognostic value of nocturnal melatonin levels as a novel marker in patients with ST-segment elevation myocardial infarction

The American Journal of Cardiology
Alberto Dominguez-RodriguezRussel J Reiter

Abstract

We evaluated the possible relation between circulating levels of nocturnal melatonin, C-reactive protein, and the development of adverse cardiovascular events in patients with ST-segment elevation myocardial infarction. Patients who had developed adverse events during follow-up had significantly lower nocturnal melatonin levels than patients without events.

References

Jan 15, 1990·The American Journal of Cardiology·B C BerkR W Alexander
May 1, 1997·Journal of Pineal Research·M R Kelly, G Loo
May 11, 1999·The American Journal of Cardiology·S AranginoG B Melis
Jun 26, 2003·Journal of Pineal Research·Cem EkmekciogluWolfgang Marktl
Dec 17, 2003·Journal of Pineal Research·Carmen RodriguezRussel J Reiter

❮ Previous
Next ❯

Citations

Aug 25, 2012·Expert Opinion on Investigational Drugs·Ludovit PaulisMoshe Laudon
Apr 10, 2013·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Alberto Dominguez-RodriguezRussel J Reiter
Jan 27, 2010·Brain Injury : [BI]·T A BekinschteinF F Manes
Apr 28, 2012·Journal of Pineal Research·Alberto Dominguez-RodriguezRussel J Reiter
Nov 18, 2014·Frontiers in Physiology·Jitka A I Virag, Robert M Lust
Feb 5, 2019·Journal of Pineal Research·Tomofumi MisakaYasuchika Takeishi
Feb 24, 2019·Nature Reviews. Cardiology·Sandra CrnkoLinda W Van Laake
May 16, 2020·Frontiers in Physiology·Zhenhong FuYundai Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.